August 01, 2019
Lupin Pharmaceuticals Inc. is recalling 11,832 bottles of lisinopril and hydrochlorothiazide tablets after a customer reported finding a fenofibrate tablet in a bottle, according to the July 31, 2019, US Food and Drug Administration (FDA) Enforcement Report.
The recall affects lisinopril and hydrochlorothiazide tablets, 20 mg/12.5 mg, in 500-count bottles (NDC 68180-519-02) from lot H801815 (Exp. 3/21). The bottles were distributed throughout the United States.
Lupin Pharmaceuticals voluntarily initiated the recall July 19, 2019. At press time, the FDA had not yet classified the recall.
Lisinopril and hydrochlorothiazide tablets are available with a prescription for the treatment of hypertension.